Cytokinetics, Incorporated

CYTK stock score: 45/100

$62.86 · -1.70% · Scored Oct 21, 2026

Technical
51
Fundamental
40
News
54

The reading

Cytokinetics (CYTK) scores 45 out of 100, which reads weak, higher than 49% of Healthcare stocks and 30% of the 4,166 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 51, fundamentals 40.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 37 and contrarian oscillators 56.

News sentiment is neutral at 54; it is shown, not counted in the composite.

Since Jul 24, 2026 the composite has ranged from 42 to 70, and it is down 16 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward CYTK’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

40

Pulling it up

  • Quick Ratio100

    Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Current Ratio100

    Current ratio measures ability to pay short-term liabilities with current assets.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • EV/Revenue0

    EV/Revenue compares the whole company's value, debt included, with its sales.

34 weighted scorers; 7 had no data today and are left out rather than counted as zero.

Technical · daily

37

Pulling it up

  • Parabolic SAR (PSAR)100

    Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • MACD (12)85

    Moving Average Convergence Divergence tracks the relationship between two exponential moving averages.

  • Bollinger Bands (50)80

    Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

Holding it back

  • Candlestick Patterns0

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Ichimoku Cloud0

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • SMA 100 Cross Up2

    SMA 100 Cross Up identifies when shorter averages cross above the 100-period SMA.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
54

Technical score by timeframe

ChartScoreWeight
Hourly461
Daily373
Weekly472
Monthly652
Quarterly652

Composite score, last 90 days

05010045Jul 24, 2026Oct 21, 2026Jul 24, 2026: 61Jul 25, 2026: 70Jul 26, 2026: 70Jul 27, 2026: 70Jul 28, 2026: 70Jul 29, 2026: 58Jul 30, 2026: 60Jul 31, 2026: 69Aug 2, 2026: 53Aug 3, 2026: 50Aug 5, 2026: 51Aug 6, 2026: 53Aug 7, 2026: 53Aug 8, 2026: 54Aug 9, 2026: 54Aug 10, 2026: 55Aug 11, 2026: 55Aug 12, 2026: 54Aug 13, 2026: 56Aug 14, 2026: 53Aug 15, 2026: 54Aug 16, 2026: 54Aug 17, 2026: 55Aug 18, 2026: 56Aug 19, 2026: 57Aug 20, 2026: 58Aug 22, 2026: 52Aug 23, 2026: 52Aug 24, 2026: 52Aug 25, 2026: 53Aug 26, 2026: 54Aug 27, 2026: 53Aug 28, 2026: 48Aug 29, 2026: 48Aug 30, 2026: 48Aug 31, 2026: 47Sep 1, 2026: 49Sep 2, 2026: 50Sep 3, 2026: 50Sep 4, 2026: 49Sep 5, 2026: 50Sep 6, 2026: 50Sep 7, 2026: 50Sep 8, 2026: 52Sep 9, 2026: 50Sep 10, 2026: 50Sep 11, 2026: 50Sep 12, 2026: 50Sep 13, 2026: 50Sep 14, 2026: 49Sep 15, 2026: 46Sep 16, 2026: 47Sep 17, 2026: 46Sep 18, 2026: 46Sep 19, 2026: 47Sep 20, 2026: 47Sep 21, 2026: 46Sep 22, 2026: 46Sep 23, 2026: 46Sep 24, 2026: 46Sep 25, 2026: 44Sep 26, 2026: 45Sep 27, 2026: 45Sep 28, 2026: 45Sep 29, 2026: 45Sep 30, 2026: 46Oct 1, 2026: 45Oct 2, 2026: 45Oct 3, 2026: 45Oct 4, 2026: 45Oct 5, 2026: 43Oct 6, 2026: 42Oct 7, 2026: 43Oct 8, 2026: 43Oct 9, 2026: 44Oct 10, 2026: 44Oct 11, 2026: 44Oct 12, 2026: 44Oct 13, 2026: 43Oct 14, 2026: 44Oct 15, 2026: 46Oct 16, 2026: 44Oct 17, 2026: 44Oct 18, 2026: 44Oct 19, 2026: 45Oct 20, 2026: 46Oct 21, 2026: 45
Show the daily numbers
DateComposite
Oct 21, 202645
Oct 20, 202646
Oct 19, 202645
Oct 18, 202644
Oct 17, 202644
Oct 16, 202644
Oct 15, 202646
Oct 14, 202644
Oct 13, 202643
Oct 12, 202644
Oct 11, 202644
Oct 10, 202644
Oct 9, 202644
Oct 8, 202643
Oct 7, 202643
Oct 6, 202642
Oct 5, 202643
Oct 4, 202645
Oct 3, 202645
Oct 2, 202645
Oct 1, 202645
Sep 30, 202646
Sep 29, 202645
Sep 28, 202645
Sep 27, 202645
Sep 26, 202645
Sep 25, 202644
Sep 24, 202646
Sep 23, 202646
Sep 22, 202646
Sep 21, 202646
Sep 20, 202647
Sep 19, 202647
Sep 18, 202646
Sep 17, 202646
Sep 16, 202647
Sep 15, 202646
Sep 14, 202649
Sep 13, 202650
Sep 12, 202650
Sep 11, 202650
Sep 10, 202650
Sep 9, 202650
Sep 8, 202652
Sep 7, 202650
Sep 6, 202650
Sep 5, 202650
Sep 4, 202649
Sep 3, 202650
Sep 2, 202650
Sep 1, 202649
Aug 31, 202647
Aug 30, 202648
Aug 29, 202648
Aug 28, 202648
Aug 27, 202653
Aug 26, 202654
Aug 25, 202653
Aug 24, 202652
Aug 23, 202652
Aug 22, 202652
Aug 20, 202658
Aug 19, 202657
Aug 18, 202656
Aug 17, 202655
Aug 16, 202654
Aug 15, 202654
Aug 14, 202653
Aug 13, 202656
Aug 12, 202654
Aug 11, 202655
Aug 10, 202655
Aug 9, 202654
Aug 8, 202654
Aug 7, 202653
Aug 6, 202653
Aug 5, 202651
Aug 3, 202650
Aug 2, 202653
Jul 31, 202669
Jul 30, 202660
Jul 29, 202658
Jul 28, 202670
Jul 27, 202670
Jul 26, 202670
Jul 25, 202670
Jul 24, 202661

Key facts

Market cap
$8.7B
Sector
Healthcare
Industry
Biotechnology
Beta
0.41
Risk grade (1–10)
6
Next earnings
Nov 4, 2026

Biotechnology peers

CompanyMarket capScore
KYMR Kymera Therapeutics$9.3B52
IBRX ImmunityBio$9.2B53
CAI Caris Life Sciences$9.1B58
PTGX Protagonist Therapeutics$8.9B57
SYRE Spyre Therapeutics$8.7B52
ARWR Arrowhead Pharmaceuticals$8.3B47

Questions

What is CYTK's stock score today?

CYTK scores 45/100 (Weak) as of Oct 21, 2026: technical 51, fundamental 40, and news sentiment 54, which is shown but not counted. Scores are recomputed every night.

Is CYTK a buy?

The score is not a buy or sell recommendation. A 45 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the CYTK score calculated?

96 weighted scorers feed it today: 34 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.